Royal Bank of Canada
RY
The Toronto-Dominion Bank
TD
Bank of Nova Scotia
BNS
Bank of Montreal
BMO
Canadian Imperial Bank of Commerce
CM
CA Stock MarketDetailed Quotes
MRV Nuvo Pharmaceuticals Inc
- 1.350
- 0.0000.00%
15min DelayMarket Closed Apr 11 09:30 ET
15.37MMarket Cap-19.29P/E (TTM)
0.000High0.000Low0Volume0.000Open1.350Pre Close0.00Turnover1.35052wk High0.00%Turnover Ratio11.39MShares1.35052wk Low-0.07EPS TTM15.37MFloat Cap1.350Historical HighLossP/E (Static)11.39MShs Float1.350Historical Low-2.83EPS LYR0.00%Amplitude--Dividend TTM1.81P/B1Lot Size--Div YieldTTM
Nuvo Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -5.20%5.18M | -16.51%5.65M | -126.07%-807K | -13.70%20.84M | -25.68%5.52M | -30.50%5.46M | 71.97%6.77M | -39.03%3.1M | 922.09%24.15M | -10.46%7.42M |
| Net income from continuing operations | 102.52%447K | 99.87%18.28M | 111.30%2.03M | -679.97%-32.21M | -333.14%-5.59M | -527.47%-17.77M | 565.02%9.15M | -940.43%-17.99M | -221.48%-4.13M | 673.92%2.4M |
| Operating gains losses | -114.97%-779K | -112.83%-16.99M | -114.67%-2.75M | 38.34%14.82M | 123.23%463K | 23.46%5.2M | -2,047.07%-7.98M | 128.27%18.77M | 134.12%10.71M | -574.52%-1.99M |
| Depreciation and amortization | -20.93%1.6M | -12.87%1.77M | -8.67%1.9M | -13.03%8.05M | -15.98%1.93M | -10.18%2.02M | -14.29%2.03M | -11.62%2.08M | -3.04%9.26M | -0.91%2.29M |
| Asset impairment expenditure | -94.99%735K | 2,164.41%1.22M | 405.56%91K | 744.57%18.21M | 67.48%3.57M | 293,740.00%14.68M | -240.48%-59K | 12.50%18K | -91.06%2.16M | 864.25%2.13M |
| Remuneration paid in stock | -21.86%497K | 43.13%1.67M | 13.79%231K | 3,286.49%2.36M | 1,245.16%355K | 1,277.78%636K | 19,300.00%1.16M | 3,960.00%203K | 30.84%-74K | -6.90%-31K |
| Remuneration paid in stock | -26.83%30K | -119.05%-8K | -5.71%99K | -12.26%229K | -15.09%45K | -18.00%41K | -20.75%42K | 0.00%105K | -42.89%261K | -53.51%53K |
| Other non cashItems | 15.43%1.52M | -74.35%286K | 125.62%154K | 287.32%4.49M | -3.94%1.02M | -10.29%1.32M | -19.96%1.12M | 78.27%-601K | -88.88%1.16M | -75.76%1.07M |
| Change In working capital | 268.91%1.13M | -143.02%-567K | -599.41%-2.56M | 1.75%4.89M | 147.45%3.73M | -124.18%-669K | -19.39%1.32M | 145.43%512K | 134.19%4.81M | 18.20%1.51M |
| -Change in receivables | -112.20%-62K | 916.10%2.38M | -267.82%-3.08M | -85.58%1.44M | -23.55%2.06M | -78.97%508K | -105.89%-292K | -789.36%-836K | 350.41%9.97M | 39.84%2.69M |
| -Change in inventory | 200.72%418K | -146.50%-617K | -11.85%-736K | 116.15%573K | 86.83%-235K | 195.86%139K | 364.87%1.33M | 42.53%-658K | -798.23%-3.55M | -690.73%-1.78M |
| -Change in payables and accrued expense | 132.45%503K | -450.62%-2M | -6.88%1.18M | 442.39%2.43M | 195.32%2.14M | -2,683.33%-1.55M | 122.26%569K | 19.25%1.26M | 93.97%-710K | 255.13%726K |
| -Change in other current assets | 15.81%271K | 19.93%-229K | -89.62%77K | 150.11%452K | -87.40%-238K | -46.33%234K | -8.75%-286K | 178.27%742K | -176.70%-902K | 73.76%-127K |
| -Change in other current liabilities | --0 | ---109K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -5.20%5.18M | -16.51%5.65M | -126.07%-807K | -13.70%20.84M | -25.68%5.52M | -30.50%5.46M | 71.97%6.77M | -39.03%3.1M | 922.09%24.15M | -10.46%7.42M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 72.86%-54K | 66.15%-44K | -114.17%-36K | 57.39%-242K | 72.12%-167K | -306.12%-199K | -225.00%-130K | 1,254.55%254K | 78.40%-568K | -8,457.14%-599K |
| Net PPE purchase and sale | -2,600.00%-54K | -633.33%-44K | 88.18%-13K | 41.33%-220K | 77.13%-102K | 77.78%-2K | 85.00%-6K | -400.00%-110K | -351.81%-375K | -6,271.43%-446K |
| Net intangibles purchas and sale | --0 | --0 | -106.32%-23K | 88.60%-22K | 57.52%-65K | -392.50%-197K | ---124K | --364K | ---193K | ---153K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 72.86%-54K | 66.15%-44K | -114.17%-36K | 57.39%-242K | 72.12%-167K | -306.12%-199K | -225.00%-130K | 1,254.55%254K | 78.40%-568K | -8,457.14%-599K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 12.64%-3.28M | -6.81%-3.28M | 2.35%-3.53M | 39.94%-13.63M | 13.61%-3.18M | -0.99%-3.76M | 13.50%-3.07M | 69.17%-3.62M | -506.17%-22.69M | -9.65%-3.68M |
| Net issuance payments of debt | 12.64%-3.28M | -6.81%-3.28M | 2.35%-3.53M | 39.94%-13.63M | 13.61%-3.18M | -0.99%-3.76M | 13.50%-3.07M | 69.17%-3.62M | -506.17%-22.69M | -9.65%-3.68M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 12.64%-3.28M | -6.81%-3.28M | 2.35%-3.53M | 39.94%-13.63M | 13.61%-3.18M | -0.99%-3.76M | 13.50%-3.07M | 69.17%-3.62M | -506.17%-22.69M | -9.65%-3.68M |
| Net cash flow | ||||||||||
| Beginning cash position | 4.83%28.58M | 11.76%26.55M | 29.68%30.87M | 3.42%23.81M | 34.59%28.41M | 58.91%27.27M | 45.72%23.75M | 3.42%23.81M | -18.01%23.02M | 14.28%21.11M |
| Current changes in cash | 22.34%1.84M | -34.74%2.33M | -1,521.11%-4.38M | 679.44%6.98M | -30.96%2.17M | -63.21%1.5M | 923.50%3.57M | 95.96%-270K | 122.32%895K | -36.20%3.14M |
| Effect of exchange rate changes | 333.43%838K | -400.00%-295K | -77.67%48K | 185.05%91K | 166.22%294K | -162.04%-359K | -111.61%-59K | 732.35%215K | 89.76%-107K | -17.46%-444K |
| End cash Position | 10.03%31.26M | 4.83%28.58M | 11.76%26.55M | 29.68%30.87M | 29.68%30.87M | 34.59%28.41M | 58.91%27.27M | 45.72%23.75M | 3.42%23.81M | 3.42%23.81M |
| Free cash from | -2.64%5.12M | -15.54%5.61M | -129.47%-843K | -14.06%20.11M | -21.16%5.35M | -32.62%5.26M | 70.40%6.64M | -43.39%2.86M | 926.49%23.4M | -18.08%6.79M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Trending Stocks
Big Five Big Five
The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.